Financial reports
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
2 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
11 Apr 24
8-K
Full Year Financial Results, and 2024 Guidance
13 Mar 24
8-K
KORU MEDICAL SYSTEMS, INC. ANNOUNCES 2023 THIRD QUARTER FINANCIAL RESULTS and updates full year 2023 outlook
8 Nov 23
8-K
Koru Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
4 Oct 23
8-K
Koru Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
9 Aug 23
8-K
Koru Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
2 Aug 23
8-K
Koru Medical Systems, Inc. Names Andrew Lafrence As Chief Financial Officer
27 Jun 23
8-K
Entry into a Material Definitive Agreement
17 May 23
8-K
Koru Medical Systems, Inc. Announces 2023 First Quarter Financial Results
4 May 23
8-K
KORU Medical Systems Announces 2022 Q4 AND full year Financial Results, Accelerating to 19% REVENUE GROWTH in 2022
8 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
18 Jul 23
S-3/A
Shelf registration (amended)
26 May 23
S-3
Shelf registration
17 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
17 May 23
8-A12B/A
Registration of securities on exchange (amended)
17 May 23
S-8
Registration of securities for employees
30 Jun 22
S-8
Registration of securities for employees
7 Jan 22
424B5
Prospectus supplement for primary offering
22 Jun 20
424B5
Prospectus supplement for primary offering
18 Jun 20
Proxies
DEF 14A
Definitive proxy
28 Mar 24
PRE 14A
Preliminary proxy
18 Mar 24
DEF 14A
Definitive proxy
29 Mar 23
DEF 14A
Definitive proxy
18 Mar 22
PRE 14A
Preliminary proxy
7 Mar 22
DEF 14A
Definitive proxy
5 Apr 21
PRE 14A
Preliminary proxy
23 Mar 21
DEFA14A
Additional proxy soliciting materials
31 Mar 20
DEF 14A
Definitive proxy
6 Mar 20
DEFA14A
Additional proxy soliciting materials
29 Mar 19
Other
EFFECT
Notice of effectiveness
1 Jun 23
CORRESP
Correspondence with SEC
26 May 23
UPLOAD
Letter from SEC
22 May 23
EFFECT
Notice of effectiveness
21 May 20
CORRESP
Correspondence with SEC
18 May 20
UPLOAD
Letter from SEC
18 May 20
EFFECT
Notice of effectiveness
12 Mar 20
CERT
Certification of approval for exchange listing
16 Oct 19
EFFECT
Notice of effectiveness
11 Mar 19
CORRESP
Correspondence with SEC
5 Mar 19
Ownership
4
Joseph M. Jr. Manko
1 Apr 24
4
EDWARD WHOLIHAN
1 Apr 24
4
Shahriar Matin
1 Apr 24
4
Donna French
1 Apr 24
4
R JOHN FLETCHER
1 Apr 24
4
ROBERT CASCELLA
1 Apr 24
4
Linda M Tharby
15 Mar 24
4
Joseph M. Jr. Manko
16 Feb 24
SC 13G
First Light Asset Management, LLC
14 Feb 24
SC 13G/A
Archon Capital Management LLC
13 Feb 24